SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COMMON STOCK
Total 13F shares
14,793,662
Share change
+2,789,126
Total reported value
$124,115,199
Put/Call ratio
89%
Price per share
$8.39
Number of holders
88
Value change
+$16,878,346
Number of buys
54
Number of sells
36

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2015

As of 30 Sep 2015 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 14,793,662 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, Cormorant Asset Management, LLC, Wildcat Capital Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, NUMERIC INVESTORS LLC, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, BANK OF AMERICA CORP /DE/, and Aisling Capital LLC.
This table shows 88 institutional shareholders of the security as of 30 Sep 2015.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.